- Home
- ZTEK vs NTRB Comparison
ZTEK vs NTRB Comparison
Compare ZTEK & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZTEK
- NTRB
- Stock Information
- Founded
- ZTEK 2008
- NTRB 2016
- Country
- ZTEK Canada
- NTRB United States
- Employees
- ZTEK N/A
- NTRB N/A
- Industry
- ZTEK Major Chemicals
- NTRB Industrial Specialties
- Sector
- ZTEK Industrials
- NTRB Health Care
- Exchange
- ZTEK Nasdaq
- NTRB Nasdaq
- Market Cap
- ZTEK 89.3M
- NTRB 93.2M
- IPO Year
- ZTEK N/A
- NTRB N/A
- Fundamental
- Price
- ZTEK $0.85
- NTRB $6.93
- Analyst Decision
- ZTEK
- NTRB Buy
- Analyst Count
- ZTEK 0
- NTRB 1
- Target Price
- ZTEK N/A
- NTRB $13.00
- AVG Volume (30 Days)
- ZTEK 135.1K
- NTRB 48.5K
- Earning Date
- ZTEK 11-13-2025
- NTRB 12-03-2025
- Dividend Yield
- ZTEK N/A
- NTRB N/A
- EPS Growth
- ZTEK N/A
- NTRB N/A
- EPS
- ZTEK N/A
- NTRB N/A
- Revenue
- ZTEK $678,078.00
- NTRB $2,578,059.00
- Revenue This Year
- ZTEK N/A
- NTRB $560.75
- Revenue Next Year
- ZTEK N/A
- NTRB $588.39
- P/E Ratio
- ZTEK N/A
- NTRB N/A
- Revenue Growth
- ZTEK 2519.47
- NTRB 42.92
- 52 Week Low
- ZTEK $0.62
- NTRB $2.98
- 52 Week High
- ZTEK $1.84
- NTRB $9.42
- Technical
- Relative Strength Index (RSI)
- ZTEK 52.77
- NTRB 44.85
- Support Level
- ZTEK $0.78
- NTRB $7.00
- Resistance Level
- ZTEK $0.90
- NTRB $8.25
- Average True Range (ATR)
- ZTEK 0.07
- NTRB 0.55
- MACD
- ZTEK 0.01
- NTRB -0.06
- Stochastic Oscillator
- ZTEK 74.27
- NTRB 4.63
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.